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Siry Genomic instability or microsatellite instability (MI) in simple repeated sequences was initially
recognised in colonic carcinomas and subsequently in other tumours. MI has been associated with mutations
in genes concerned with replication and DNA repair. We investigated 34 microsatellite markers in squamous
cell carcinoma of the head and neck (SCCHN). Fifty-six tumours, were studied, of which 25 were investigated
with ten or more microsatellite markers. In this study we consider two or more microsatellite alterations in a
tumour to be diagnostic of MI. We demonstrated that 7/25 (28%) of the tumours had MI at two or more loci
and three of these tumours exhibited evidence of 20 or more loci with MI. No correlations were found
between MI and previous treatment, site, histological differentiation, positive nodes at pathology, a history of
alcohol intake or survival. MI has been demonstrated in TINO stage tumours, indicating that these changes
may occur early in the disease process. A negative correlation was found between MI and a history of smoking
(P = 0.02). Two or more markers of MI were found in three of four non-smokers compared with one of 13 in
the smoking group of patients, which suggests a novel mechanism of carcinogenesis in non-snokers.
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Genomic instability at simple repeated sequences or micro-
satellite instability (MI) has been recognised in carcinoma of
the colon (Aaltonen et al., 1993; Ionov et al., 1993;
Thibodeau et al., 1993) and in a number ofother carcinomas.
Initially it was considered that there was a subset of colonic
carcinomas in which these ubiquitous somatic mutations
occurred only in microsatellites. Therefore, it was postulated
that, as these mutations were associated with certain
genotypic, phenotypic and clinical parameters, this indicated
a new carcinogenic process in colonic cancer. Furthermore,
as MI was found in all the specimens from patients with
multiple tumours and adenomas, it was proposed that a
mutation had occurred in the DNA repair gene (Shibata et
al., 1994). MI has now been correlated with mutations in the
hMSH2, hMLHI, hPMSI and hPMS2 genes which have
homology to bacterial and yeast genes participating in mis-
match repair (Aaltonen et al., 1993; Bodmer et al., 1994;
Nicolaides et al., 1994; Papadopoulos et al., 1994; Shibata et
al., 1994). Furthermore, mutations in these mismatch repair
genes have been linked to loci on chromosomes 2pl5-16,
3p21-23, 2q31-33 and 7p22 (hMSH2, hMLHI, hPMSI and
hPMS2) in hereditary non-polyposis colorectal cancer
(HNPCC; Lynch syndrome) (Lindblom et al., 1993; Pel-
tomaki et al., 1993; Nicolaides et al., 1994; Papadopoulos et
al., 1994). Mutation of the microsatellite repeats originates as
slippage owing to strand misalignment during DNA replica-
tion, without preference for contraction or expansion of the
parental allele (Richards and Sutherland, 1994). Sequencing
of the novel microsatellite alleles has demonstrated that ins-
tability is more common in markers consisting of larger
repetitive units and it is considered to be an early event in
malignant progression (Shibata et al., 1994). Although a
number of reports exist on MI in various tumours, its real
significance in tumour progression is unknown.
In this study we have analysed SCCHN specimens for MI
using 34 microsatellite markers, in order to ascertain whether
MI is a feature of developing head and neck cancer. The
results presented indicate that MI is a phenomenon of
SCCHN and most likely plays an important role in the
development of these tumours, especially in non-smokers.
Materiak and methods
Specinens and DNA extraction
Squamous cell carcinoma of the head and neck (SCCHN)
samples from the hypopharynx, oropharynx, mouth and
larynx were obtained from the Department of Otorhino-
laryngology, Royal Liverpool University Hospital, and the
Maxillofacial Unit, Walton Hospital, Liverpool, UK. All the
specimens were taken at the time of surgery and frozen in
liquid nitrogen. Subsequently frozen sections were prepared
and dissected to provide tissue samples with over 50%
tumour material; in most cases the DNA was prepared from
samples with over 70% tumour cells. Complete clinical data
were available in the majority of the cases investigated.
Genomic DNA was extracted from the frozen tissues using
the Nucleon LI DNA extraction kit from Scotlab, following
the manufacturer's instructions. Genomic DNA samples were
stored at 4"C.
Microsatellite analysis
The 34 microsatellite markers on ten chromosomes used in
this study are listed in Table I. The primers were obtained
from Isogen (Amsterdam). Polymerase chain reactions
(PCRs) were performed in a 25 gl reaction volume and con-
tained 200 ng of genomic DNA, 500 gM dNTP, 10 pmol of
each forward and reverse primer, 2.5 gIl of 10 x PCR buffer
[670 mM Tris-HCl pH 8.5, 166 mM ammonium sulphate,
67 mM magnesium chloride, 1.7 mg ml' bovine serum
albumin (BSA), 100 mM -mercaptoethanol, 1% (w/v) Triton
X-100] and 0.5 units of Taq DNA polymerase. The reactions
were denatured for 4 min and the DNA was subsequently
amplified for 25 cycles of 94C for 30 s, 58°C for 30 s and
72°C for 33 s. A 10 gil volume of the PCR product was
analysed in a 10% polyacrylamide gel and visualised by silver
staining. Microsatellite instability was scored in all of the
SCCHN specimens analysed by a demonstration of a shift of
one or both of the alleles in the tumour DNA specimen as
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Table I Microsatel}ite instability assessed with 34 mirosatellite markers in
squamous cell carcinomas of the head and neck
Nwmber of
Nnmber of SCCHN Percentage
Microsatellite marker SCCHNanalysed with MI ofMI
D2S123 (chromosome 2) 35 5 14
D4S43 (chromosome 4) 19 1 5
HOX7 16 3 19
GARBI 15 0 0
D4S392 18 5 28
D4S194 17 4 24
D4S243 15 2 13
D6S344 (chromosome 6) 14 3 21
TRM1 16 3 19
D6S271 17 4 24
D6S286 20 2 10
D6S262 28 5 18
D6S281 21 2 10
D7S550 (chromosome 7) 21 3 14
D7S473 15 2 13
D7S531 20 2 10
D8S201 (chromosome 8) 37 5 14
D8S87 45 5 11
ANKI 49 1 2
D8S166 18 2 11
D8S164 29 3 10
D8S88 35 4 11
D8S85 31 2 6
D8S198 15 0 0
MYC 35 3 9
DlQS249 (chromosome 10) 21 2 10
DIOS109 21 3 14
DlQS212 20 3 15
D13S175 (chromosome 13) 34 7 21
TCRD (chromosome 14) 13 3 23
D16S303 (chromosome 16) 18 3 17
HBAP1 24 2 12
D17S520 (chromosome 17) 12 2 17
GP3A 38 3 8
This tablerepresentsthetotalnumberofspecimensanalysed forMI in SCCHN.
All specimens producing a detectable PCR product are recorded, i.e. both
homozygousandheterozygousresultsareinduded,sinceMIisvisibleinbothtypes
ofalleic patterns.
Table k Mirosatellite instability in 25 SCCHN specimen eamined with a minimum of ten
microsatelite markers
No. of
SCCHN No. of loci with
specimen loci microsatellite
number examined instability (%) Microsatellite instability affected markers
184 34 25 (71) D2S123; HOX7, D4S392, D4S194, D4S243;
D6S344, D6S271, D6S262; D7S550, D7S473,
D7S531; D8S201, D8S87, D8S166, D8S164,
D8S88, D8S85, MYC; DIOS109, D10S212,
D13S175; TCRD, D16S303, HBAP1, D17S520
228 28 21 (75) D2S123; HOX7, D4S392, D4S194; D6S344,
TRM1, D6S271, D6S262, D6S281, D7S550,
D7S473; D8S201, ANKI, D8S164, D8S88, MYC;
D10S249, D1OS109, D10S212, D13S175, TCRD
224 31 20 (65) HOX7, D4S392, D4S243; D6S344, TRMI,
D6S271, D6S286, D6S262; D7S531; D8S87,
ANKI, D8S166, D8S164, D7S88, MYC;
D10S212, DIOSJO9, D10S249, TCRD, HBAP1
353 22 3 (14) D6S286; D7S550, MYC
335 10 3 (30) D4S194; D4S392; D13S175
338 31 2 (6) D4S243; D13S175
91 22 2 (9) D6S281; D8S164
336 32 1 (3) D13S175
204 29 1 (3) D16S303
302 28 1 (4) D7S550
305 25 1 (4) D13S175
339 24 1 (4) D4S194
218 22 1 (4) D8S85
192 22 1 (4) TRM1
101 21 1 (5) D8S88
343 20 1 (5) D8S201
350 14 1 (5) D6S262
180 10 1 (10) D8S88
The following seven specimens analysed with a minimum of ten markers had no evidence of
microsatellite instability. Patient number given with number ofmicrosatelte markers analysed in
parenthesis. 348 (30); 161 (28); 87 (24); 225 (18); 100 (12); 75 (11); 202 (10).compared with the normal DNA specmen. The shift was
indicated by either an addition or deletion of one or more
repeat units.
Statistical analysis
Quantitative data were analysed by z or Fisher's exact test
where appropriate. Survival curves were drawn up usng the
Kaplan-Meier product limit etimate (Kaplan and Meier,
1958). Differences between survival tmes were analysed by
the log-rank method (Peto et al., 1976).
Rea b
Fifty-six tumours were assessed for microsatellite instability
with a wide range of markers, but not all tumours were
investigated with all of the 34 microsatellite markers. Table I
lists the numbers ofspecmen investigated for each ofthe 34
markers, which totals over 1500 paired PCRs. We analysed
in detail the clinical data of 25 SCCHN patients whose
specimens were examined with a minimum of ten microsatel-
lite markers (range 10-38 markers). In this study we do not
regrd the presence of one microsatellite alteration as diag-
nostic of microsateilite instability, thus our cinical correla-
tions are alculated on the basis of micosatellite instability
being demonstrated in two or more markers. The results of
this analysis indicated that 28% (7/25) of SCCHN were
found to have MI in two or more microsatellite markers and
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three of these tumours had 20 or more microsatellite shifts
(Table H). These MI alterations often appeared as single new
bands (Figure 1) in comparison with the 'ladders' seen in
HNPCC cancers (Aaltonen et al., 1993). The highest
incidence of MI was found on chromosome 4 at D4S392
(28%). The incidence of MI in different microsatellite
markers varies considerably: six microsatellite markers dem-
onstrated shifts in over 20% of the tumour samples studied
for each marker, whereas 12 had 10% or less (Table I). All
but two of the microsatellites are dinucleotide repeats;
GARBI and D4S243 are trinucleotide repeats showing 0%
and 13% incidence of MI respectively.
The level of MI was assessed with a range of clinico-
pathological parameters in these 25 SCCHN patients, includ-
ing previously untreated and previously treated with
radiotherapy or surgery or both; site; histological differen-
tiation; positive nodes at pathology, TNM staging survival;
and also with the patients' smoking and drinking history. No
correlations were found between MI and previously treated
and previously untreated tumours, site, level of pathological
differentiation, nodes at pathology or a history of drinking.
Two of the four TNM stage I tumours had evidence of MI,
indicating that this phenomenon is common in the earliest
stages of the disease (Tables Ill and lV).
Smoking data were available for 17 of these patients, and
in this subset of patients three of four non-smokers had
evidence of MI; in fact, two ofthese patients had 20 or more
markers of MI (Table V). On comparing MI (two or more
markers) in the non-smokers with all of the smokers, a
Patient 184
DlOS212
N T
HBAP1
N T
D17S520
N T
4
Patient 224
D4S392
N T
D8S87
N T
4
Patient 184
D4S392
N T
TCRD
N T
HBAP1
N T
4
Patient 224
D1OS109
N T
D1OS249
N T
4
Fwe I MicrosateIlite instability detected in squamoucell caromas of the head and neck N, normal DNA; T, tumour DNA.
Representative eampl of MI in SCCHN in patients 184 and 224. The novel aleles in the tumour sample are indicated by the
filled arrow (4). s wer observed im patit 184 within the marks D4S392 (m both allels), D1OS212 and HBAP1, and in
patient 224 in the marker DIOS249. DetioD5 were observed in patient 184 in the marker D17S520 and in patient 224 in the
markers D4S392, D8S87, TCRD, HBAPI and D1OS109. Patient 184 was found to be heterozygous for the marker HBAPI in
norml tissu, however the two parental bands wer affected diffcretly in the tumour There are two interpetations for
this findig: (i) the upper band was shifted, ting MI, and the loer band was lst, indiating oss of heterozygosity; CiH) a
coinidental shift ofthe two mutated aileles n the tumour DNA with insertion ofone repeat in the large allele and of two repeats
in the small ale (1l).-c Il bimblty n had an nck cac
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Table I Microsatellite instability in 25 SCCHN compared with
cinicopathological parameters in SCCHN
MI in two or more
markers/no
Clinical parameter specimens analysed Percentage P
Site
Hypopharynx 3/10 30
Oropharynx 1/2 50
Mouth 3/9 33 NS
Larvnx 014 0
Previously untreated 5 17 29
Previously treated 2/8 25 NS
Pathology
Well differentiated 1/4 25
Moderately differentiated 3/15 20 NS
Poorly differentiated 2/3 67
TNM stage
I 224 50
II 0,2 0 NS
In 2/8 25
IV 3/10 30
Table IV Microsatellite instability in 25 SCCHN compared with
clinicopathological parameters in SCCHN
No. ofpatients No. patients
Clinicalparameter analysed dead P
Survival
MI in fewer than two 18 6
markers
MI in two or more markers 7 2 NSa
'Fisher's exact test and log-rank method.
significant difference was found (P = 0.02). No statistical
difference was found between the non-drinkers and patients
with a history of moderate or heavy drinking (Table VI). The
follow-up data of these patients (range 6-90 months)
indicate that, of 18 patients with no evidence of MI, six have
died to date, while in the group of seven patients with MI,
two have died, indicating no correlation between MI and
survival.
Diusaso
The results of this investigation indicate that MI is a detec-
table phenomenon in SCCHN. We analysed genomic ins-
tability on ten chromosomes using 34 microsatellite markers,
and 25 of the SCCHN were examined with at least ten
microsatellite markers. In this study we have not considered
one microsatellite alteration to be diagnostic of MI. It may
be argued that some of the alterations observed in these
highly unstable sequences could be simply due to their high
background mutation rates. Thus, the clinical correlations
were based on microsatellite instability being observed in two
or more markers and 28% (7/25) of the SCCHN were found
to fall into this group. This is similar to the incidence of MI
previously reported in the literature for other cancers and
indicates that this genotype alteration is most likely an
important mechanism in the development of SCCHN. No
correlation was found between MI and previously untreated
and previously treated tumours, histological differentiation,
positive nodes at pathology, TNM staging or survival. An
association was found between high incidence of MI and the
early stage (TlNO) of this disease, however this was not
statistically significant.
We have reported a high incidence of loss of hetero-
zygosity (LOH) in SCCHN in chromosomes 3 and 17
(Adamson et al., 1994; Field et al., 1994) and in certain
markers analysed in this study (Kiaris et al., 1994; JK Field
et al., unpublished). Thus it may be argued that two
Table V Microsatellite instability in SCCHNcompared with a history
of smoking in SCCHN
Non-smoker Moderate smoker Heavy smoker
No MI 0 2 3
One marker of MI 1 0 7
Two markers of MI 1 0 0
Twenty or more 2 1 0
markers of MI
Moderate smoker, <20 cigarettes per day; heavy smoker, >20
cigarettesperday. Theheavysmokergroupcontainsoneindividualwho
was a 'stopped smoker' but was originally a heavy smoker. Correlation
between twomore moremarkers ofMI and one ornomarkersofMI in
non-smokers and smokers: P = 0.02 (Fisher's exact test).
Table VI Microsatellite instability compared with a history of
drinking in SCCHN
Moderate and
Non-drinkers heavy drinkers
No MI 3 2
One marker of MI 1 5
Two markers of MI 1 0
Twenty or more markers of MI 1 2
Moderatedrinker, <21 unitsperweek, heavydrinker, >21 unitsper
week.
mechanisms (LOH and MI) are involved in the development
of SCCHN. In particular, MI appears to be an important
mechanism in the development of SCCHN in patients who
do not smoke. These findings add further weight to the
hypothesis that the mutator phenotype is a phenomenon of
many human cancers, such as breast, ovarian, gastric, lung
and endometrial carcinomas (Risinger et al., 1993; Burks et
al., 1994; Merlo et al., 1994; Rhyu et al., 1994; Shridhar et
al., 1994; Wooster et al., 1994; Yee et al., 1994).
Only two of the microsatelltes examined in this study were
trinucleotides and they had low levels of MI (GARB1 and
D4S243 had 0% and 13% respectively), whereas we have
shown that specific dinucleotide microsatellite markers had a
high incidence of MI. The markers tested in the present study
were affected in various frequencies which range from 0% for
GARBI and D8S198, to 28% for D4S392, 21% for D6S344
and 21% for D13S175. Wooster et al. (1994) argued that
instability was a more common event in trinucleotide than
dinucleotide repeats. Our results indicate that a subset of
microsatellite markers are involved in MI as the markers
used in this study were mainly dinucleotides and exhibited a
wide range of instability frequencies. There is no evidence to
indicate that these microsatellite repeats are functional, and
thus we suggest that the aetiology of the different rates of
instability is a structural and not a functional feature of the
repetitive units.
Ionov et al. (1993) provided evidence for the mutator
phenotype hypothesis as a molecular mechanism in car-
cinogenesis. This involves a mutation in a DNA replication
or repair gene, which results in a decreased accuracy of these
systems. Therefore, the mutator mutation results in accumu-
lation of ubiquitous clonal somatic mutations in repeated
sequences. Even though the microsatellite repeats are neutral,
we can postulate that instability would affect other sequences
within the genome that are functional, and MI serves as the
marker for such genetic aberrations.
We have previously reported that a history of heavy smok-
ing correlates with overexpression of the p53 tumour-
suppressor gene (Field et al., 1991, 1992), however these new
findings provide strong support for a hypothesis that MI is a
different mechanism of carcinogenesis from that previously
reported in SCCHN (Field et al., 1989; Field, 1992).
Evidence from a number of sources, epidemiological and
molkeular, indicates that carcinogens in tobacco smoke are
one of the major contributing factors in the development of
SCCHN, however a proportion of SCCHN are also found in
1068crosslb instabiftit in hea and neck cancer
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non-smokers. It is conceivable that certain individuals may
be exposed to environmental carcinogens in particular indus-
trial situations, and that this may be a major contributory
element in the development of SCCHN in non-smokers.
Smokers will also be exposed to similar industrial car-
cinogens, but the effect of tobacco smoke may act synergis-
tically or independently of the 'environmental' carcinogens in
causing a greater number of SCCHN. Even though the
number of non-smokers investigated in this study is small,
the majority of them had evidence of MI. We propose that
MI may be considered a molecular marker of carcinogenesis
in non-smokers and that this may very well be a valuable
marker in molecular epidemiology of cancers in the future.
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